2 reports

The company' s products majorly deal in segments such as respiratory, inflammation and autoimmunity, cardiovascular and metabolic diseases, oncology, infection, neuroscience, and gastrointestinal.

  • Beta-Blocker
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.

Gastrointestinal includes Nexium ##HR/ Nexium Control.

  • Beta-Blocker
  • Ophthalmology
  • United States
  • Market Size
  • Alcon, Inc.